Alkeon Capital Management
WGS icon

Alkeon Capital Management’s GeneDx Holdings WGS Stock Holding History

Alkeon Capital Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-77,530
Closed -$11.4M – 161
2021
Q4 		$11.4M Buy
77,530
+7,575
+11% +$1.69M 0.02% 136
2021
Q3 		$17.5M Hold
69,955
– – 0.03% 137
2021
Q2 		$32.3M Sell
69,955
-45
-0.1% -$19.3K 0.05% 126
2021
Q1 		$34.4M Buy
+70,000
New +$36.4M 0.05% 123

Other funds holding WGS

Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Alkeon Capital Management's WGS Position: Q1 2022 in Review

Alkeon Capital Management sold out of GeneDx Holdings (WGS) in Q1 2022, closing a stake of 77,530 shares — an estimated $11.4M sold.

Alkeon Capital Management first reported a position in WGS in Q1 2021 and held it in 4 quarters. The position peaked at $34.4M in Q1 2021. 108 funds tracked by Wall St. Rank hold WGS as of Q1 2022.

  • Alkeon Capital Management reported no remaining GeneDx Holdings position as of Q1 2022 after selling out during the quarter.
  • Alkeon Capital Management sold 77,530 GeneDx Holdings shares in Q1 2022, an estimated $11.4M.
  • Alkeon Capital Management first reported a position in GeneDx Holdings in Q1 2021 and held it in 4 quarters.
  • Alkeon Capital Management's GeneDx Holdings position peaked at $34.4M in Q1 2021.
  • 108 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2022.

Based on Alkeon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.